Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer.
Analysts think this beaten-down healthcare stock will rebound.
Overview
Count Intuitive Surgical (NASDAQ: ISRG) among the biggest healthcare losers of 2026. The medical device stock is down close to 30% year to date. Its performance was even worse. By late July, Intuitive Surgical's share price had plunged more than 40% since the beginning of the year.
Despite this dismal trajectory, Wall Street remains overwhelmingly bullish about Intuitive Surgical. Of the 32 analysts surveyed by S&P Global (NYSE: SPGI) in September, 24 rated the stock as a "buy" or "strong buy." Only one of the other eight analysts recommended selling Intuitive.
Details
But is Wall Street dead wrong about this beaten-down stock?
Source
Originally published at www.fool.com.
Related Articles
- Retail investors are aggressively piling into this bold contrarian bet through one ETF.
- My wife never went back to work after raising our kids. Do I have to share my retirement savings 50/50?
- Warren Buffett's Successor, Greg Abel, Jettisoned Amazon Earlier This Year and More Than 6X'd Berkshire's Stake in the "Apple" of His Eye
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.